Study on Serum Electrolytes in Sickle Cell Disease Patients on Hydroxyurea Therapy Non-hydroxyurea Therapy

Sickle disease affects millions of people worldwide. Where as in India, prevalence is high in Orissa, Madhya Pradesh, Maharashtra, western regions of Gujarat and Chhattisgarh. The morbidity and mortality associated with the disease, complications and sickle cell crisis is a significant health issue....

Full description

Saved in:
Bibliographic Details
Published inIndian journal of clinical biochemistry Vol. 34; no. S1; p. S128
Main Authors Madhuri, M, Rajkumari, D.M.M
Format Journal Article
LanguageEnglish
Published Springer 24.05.2022
Subjects
Care and treatment
Electrolytes
Health aspects
Hydroxyurea
Medical research
Medicine, Experimental
Mortality
Sickle cell anemia
Urea
Online AccessGet full text

Cover

More Information
Summary:Sickle disease affects millions of people worldwide. Where as in India, prevalence is high in Orissa, Madhya Pradesh, Maharashtra, western regions of Gujarat and Chhattisgarh. The morbidity and mortality associated with the disease, complications and sickle cell crisis is a significant health issue. Hydroxyurea is an anticancer agent, which proved to be the wonder drug in lower doses in sickle cell disease. The main aim of the study is to evaluate the serum electrolytes level in sickle disease patients and find out the effect of hydroxyurea. Sickle cell disease patients and 20 normal individuals as controls are included in the study. 11 patients on hydroxyurea therapy and 13 are non-hydroxyurea therapy. The serum levels of sodium, potassium, chloride, calcium, magnesium and phosphate were estimated in all the study subjects. There is significant difference observed among Total Bilirubin, Urea, and Creatinine and chloride levels among Sickle disease patients compared with normal individuals. No much significant results were observed among patients on hydroxyurea therapy and non-hydroxy urea therapy except for Total bilirubin and Sodium levels. Electrolytes plays crucial role in the pathophysiology of sickle cell disease, but hydroxyurea therapy does not seem to alter the electrolyte levels in patients.
ISSN:0970-1915